News | News By Subject | News by Disease News By Date | Search News

Blood clotting disorders News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bay Area's Portola (PTLA) Plummets as FDA Rejects AndexXa NDA     8/19/2016
AstraZeneca PLC (AZN) Wins UK Cost Approval for Longer Use of Clot Buster Brilique     8/12/2016
Eagle Pharma (EGRX) Plunges as the FDA Rejects Blood Thinner Kangio     3/18/2016
FDA Green Lights Boehringer Ingelheim's Blood Thinner Reversal Agent Praxbind     10/19/2015
EXCLUSIVE: New Antiplatelet Therapy Could Save Limbs, Says Merck & Co. (MRK) Exec     7/2/2015
FDA Approves The Medicines Company (MDCO)'s Blood Clot Drug KENGREAL     6/24/2015
The Medicines Company (MDCO)’s Kengreal Gets FDA Support After Previous Setbacks     4/14/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi     2/20/2015
FDA Green Lights Daiichi Sankyo (DSNKY)'s New Anti-Clotting Drug     1/9/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Regado Biosciences, Inc. (RGDO) Permanently Halts Enrollment In Lead Drug Trial     8/26/2014
Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner     7/24/2014
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Clot Drug Eliquis® Gets EU Green Light For Wider Use     6/27/2014

News from Around the Web
Accuracy Concerns On Testing Device For Blood-Thinning Drug     3/18/2016
Scientists Get Closer To Detecting When And Why Blood Clots Form, Harvard Study     1/7/2016
New Blood Thinner "Antidote" To Help Doctors Move Past Warfarin     12/23/2015
Is Hummus Good For You? 6 Health Issues The Superfood Dip Can Treat     3/31/2015
Aspirin Cuts Risk Of Clots, DVT By A Third, University of Sydney Study     8/26/2014
Aspirin's Clot-Prevention Ability Blunted by Dietary Fat: American Heart Association Study     5/2/2011
Being Tall, Obese May Significantly Increase Risk of Blood Clots in Deep Veins, Tromso in Norway Study     4/29/2011
Birth Control Pills: Some Carry Higher Risk of Blood Clots, Northwestern University Study     4/22/2011
Cholesterol Drugs Could Cut Clots, University of Reading Study     3/17/2011
New Heart Drugs Don't Mean Old Ones Should be Discarded, University of Florida Researchers Say     3/9/2011
Blood-Clotting Agent Can Diagnose Fatal Genetic Diseases, University of Manchester Study Finds     2/4/2011
Firefly Protein Lights Pathway To Improved Detection Of Blood Clots, Study Published in Bioconjugate Chemistry     12/10/2010
Age No Barrier to Clot-Busting Drugs, University of Glasgow Study     11/29/2010
Antibiotic Appears Safe for Stroke Patients and Good Companion for tPA, Medical College of Georgia and University of Georgia Study Suggests     10/14/2010
Antipsychotic Drugs 'Appear to Raise Blood Clot Risk,' University of Nottingham Study     9/22/2010

Press Releases
Janssen Pharmaceutical Release: Two New Real-World Studies Confirm Positive Efficacy And Safety Profile Of XARELTO (Rivaroxaban) In Treating And Preventing Blood Clots     10/24/2016
Portola (PTLA) Announces Validation Of Marketing Authorization Application (MAA) By EMA For Indexxa (Andexanet Alfa), A Factor Xa Inhibitor Antidote     8/19/2016
Stempeutics Release: DCGI Gives Limited Approval To Market FIRST Allogeneic Cell Therapy Product In India Stempeutics Puts India On The 'World Map Of Regenerative Medicine'     5/31/2016
Boehringer Ingelheim Pharmaceuticals, Inc. Release: : Interim Phase III Data Show Praxbind (idarucizumab) Reverses Dabigatran (Pradaxa) In Emergency Situations     4/4/2016
Akers Biosciences Announces $2.5M Order To Supply PIFA Heparin/PF4 Products To China     3/2/2016
Eurostars Grant Awarded To International Consortium Including Abzena, Antitope, For Development Of Novel Treatment For Clotting Disorders     1/18/2016
FDA Clears Siemens (SI)’ New High-Volume Coagulation Analyzer     1/13/2016
Galena Biopharma  (GALE) Presents Final GALE-401 Phase II Clinical Data At The 57th American Society of Hematology Annual Meeting And Exposition     12/8/2015
Janssen Pharmaceuticals, Inc. Release: First Data Unveiled From CALLISTO Program Examining The Use Of XARELTO (rivaroxaban) For Treating Blood Clots In People With Cancer     12/7/2015
ACCU-BREAK Pharmaceuticals, Inc. Files NDA For Unique Warfarin Potassium Tablets     11/19/2015
Isis Pharma (ISIS) Initiates Phase 2 Study Of ISIS-FXI Rx In Patients With End-Stage Renal Disease On Hemodialysis     10/30/2015
Ablynx (ABLYF) Initiates A Multinational Phase III Study With Caplacizumab In Patients With Acquired TTP, A Rare Blood Clotting Disorder     9/29/2015
Portola Announces Second Part Of Phase 3 ANNEXA-R Study: Andexanet Alfa And Rivaroxaban Meets Primary And Secondary Endpoints     9/15/2015
Did C.R. Bard Really Forge a Signature on an FDA Filing?     9/8/2015
LEO Pharma Release: New Study Investigating The Effect Of Low-Molecular-Weight Heparins On The Treatment Of Blood Clots In Cancer Patients     8/19/2015

//-->